Health
WHO reveals that Hepatitis may kill more people than malaria, TB, HIV combined
The World Health Organisation has raised the alarm that viral hepatitis could kill more people than malaria, tuberculosis, and HIV combined by 2040 if the current infection rate continues.
According to WHO, hepatitis causes liver damage and cancer and kills over a million people annually. Of the 5 types of hepatitis infections, hepatitis B and C cause most of the disease and deaths.
WHO made this known in a statement it issued as the global health body joined the rest of the world to celebrate the 2023 World Hepatitis Day, themed, “One life, one liver”.
The health organisation noted that while Hepatitis C could be cured, only 21 per cent of the people living with the infection are diagnosed and only 13 per cent have received curative treatment.
WHO added that only 10 per cent of people living with chronic hepatitis B are diagnosed, and only 2 per cent of those infected are receiving lifesaving medicine.
“Viral hepatitis could kill more people than malaria, tuberculosis, and HIV combined by 2040 if current infection trends continue.
“Hepatitis causes liver damage and cancer and kills over a million people annually. Of the 5 types of hepatitis infections, hepatitis B and C cause most of the disease and deaths. Hepatitis C can be cured; however, only 21% of people living with hepatitis C infection are diagnosed and only 13% have received curative treatment.
“Just 10 per cent of people living with chronic hepatitis B are diagnosed, and only 2per cent of those infected are receiving the lifesaving medicine.”
WHO emphasised the importance of protecting the liver against hepatitis for living a long, healthy life, saying, “Good liver health also benefits other vital organs – including the heart, b, rain, and kidneys – that rely on the liver to function.”
WHO Director-General, Dr. Tedros Adhanom Ghebreyesus, stated that despite available preventive measures and treatment, many people are undiagnosed.
“Millions of people are living with undiagnosed and untreated hepatitis worldwide, even though we have better tools than ever to prevent, diagnose and treat it.
“WHO remains committed to supporting countries to expand the use of those tools, including increasingly cost-effective curative medication, to save lives and end hepatitis,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General.
To combat viral hepatitis, WHo called for global communities to ensure access to treatment for all pregnant women and vaccines for babies at birth.
“To reduce new infections and deaths from hepatitis B and C, countries must: ensure access to treatment for all pregnant women living with hepatitis B, provide hepatitis B vaccines for their babies at birth, diagnose 90% of people living with hepatitis B and/or hepatitis C, and provide treatment to 80% of all people diagnosed with hepatitis.
“They must also act to ensure optimal blood transfusion, safe injections, and harm reduction.
“The reduction of hepatitis B infections in children through vaccination is a key intervention to limit viral hepatitis infections overall. The target for hepatitis B incidence is the only Sustainable Development Goal health target that was met in 2020 and is on track for 2030.
“However, many countries in Africa do not have access to the birth dose hepatitis B vaccines. Gavi’s recent restart of its Vaccine Investment Strategy 2018 – which includes the birth dose hepatitis B vaccine – will jumpstart newborn vaccination programs in West and Central Africa, where mother-to-child hepatitis B transmission rates remain very high.
“To help eliminate mother-to-child transmission, WHO recommends that all pregnant women should be tested for hepatitis B during their pregnancy. If positive, they should receive treatment and vaccines should be provided to their newborns. However, a new WHO report shows that of the 64 countries with a policy, only 32 countries reported implementing activities to screen for and manage hepatitis B in antenatal clinics.
“For people who want to maintain liver health, WHO recommends hepatitis testing, treatment if diagnosed, and vaccination against hepatitis B. Reducing alcohol consumption, achieving a healthy weight, and managing diabetes or hypertension also benefit liver health,” WHO stated.
Health
BREAKING: Lassa fever kills 259, infects 1,086 in 24 Nigerian states — NCDC
The Nigeria Centre for Disease Control and Prevention (NCDC) has confirmed that Lassa fever has claimed 259 lives and infected 1,086 people across 24 states and 118 local government areas so far in 2026.
In its latest Lassa Fever Situation Report for epidemiological week 36 (August 31 to September 6), the agency said the figures represent a case fatality rate of 23.9 percent — significantly higher than the 18.6 percent recorded during the same period in 2025.
Twelve new confirmed cases were recorded in week 36, a decline from the 18 cases reported the previous week. The fresh infections were detected in Ondo, Edo and Kogi states.
Five states continue to bear the heaviest burden, accounting for 87 percent of all confirmed cases this year: Bauchi, Ondo, Taraba, Benue and Edo. People aged 21 to 30 remain the most affected age group.
The NCDC noted that no new infections among healthcare workers were recorded during the latest reporting week. The agency continues to urge the public to maintain hygiene, avoid contact with rodents and their droppings, and seek early medical care if symptoms appear.
Health
Nigerian hospital successfully performs kidney cancer surgery via tele-robotic
The development could reduce the need for Nigerians to travel abroad for specialised medical treatment, thereby reducing expenditure on international travel, accommodation and medical services.
• A surgeon performing tele-robotic surgery.
Nisa Premier Hospital, Abuja, has partnered with RoboMed Global and The Redeemer’s Health Village (RHV) to successfully perform what the hospital described as the first tele-robotic surgery in Nigeria and West Africa.
The landmark kidney cancer surgery was performed on a patient at Nisa Premier Hospital, Abuja, while the surgeon, Professor Obi Ekwenna-Davis, remotely controlled the robotic surgical platform from Redeemer’s Health Village in Lagos.
The procedure, which lasted approximately three hours, was performed to remove a kidney affected by a cancerous tumour.
The hospital said the patient had been discharged following the successful procedure, although details about the patient’s identity and condition were withheld for privacy reasons.
Speaking during an event to mark the milestone, the Chief Executive Officer of Nisa Premier Hospital, Dr Ibrahim Wada, said the development demonstrated the potential of tele-robotic surgery to connect specialist surgical expertise with patients across Nigeria.
Wada said the procedure was carried out using the MicroPort robotic surgical platform installed at Nisa Premier Hospital, with the remote surgeon controlling the system from Lagos.
He said the development could reduce the need for Nigerians to travel abroad for specialised medical treatment, thereby reducing expenditure on international travel, accommodation and medical services.
According to him, the technology also creates an opportunity for Nigerians to access specialised expertise from doctors located in other parts of the world without requiring the doctors to travel physically to Nigeria.
Source: Daily Trust
Health
Ondo ‘Monkey Tail’ herbal drink kills 49
The Commissioner for Health in the State, Dr Banji Ajaka, who disclosed this on Wednesday night, said the number of affected persons has now climbed to 170.
A locally produced herbal concoctions known as ‘Monkey Tail’ in Ondo State has killed 49 people .
The Commissioner for Health in the State, Dr Banji Ajaka, who disclosed this on Wednesday night, said the number of affected persons has now climbed to 170.
He explained that the latest deaths were recorded in Irele Local Government Area of the state, where eight persons have died from suspected poisoning.
Ajaka disclosed that health authorities had deployed response teams to Irele LGA and other affected communities to conduct surveillance, manage cases and trace the source of the suspected toxic substance.
-
Business1 day agoGambia Orders Nigerian Banks To Replace Foreign Staff by December 2026
-
Business2 days agoCBN, MOF sign pact to align monetary, fiscal policies
-
Business1 day agoDangote Whets Investors Appetite Ahead 2028 Fertiliser IPO
-
Health1 day agoNigerian hospital successfully performs kidney cancer surgery via tele-robotic
-
International1 day agoTrump launches ‘Trump TV’ as US networks halt White House coverage
-
News1 day agoIndependent Panel Begins Probe into 37 Deaths in Civil Defence Custody
-
Business1 day agoFans shown 65,000 junk food ads at World Cup
-
Sports1 day agoMbappé Leaves Nike To Promote Swiss Sportswear Brand On
